Hiromu Horitani
Papers
1
Total Citations
1
H-Index
1
About
Hiromu Horitani is a surgical outcomes researcher whose work focuses on identifying preoperative biomarkers and clinical predictors that improve recovery after major urologic oncology procedures. His most-cited study, "Preoperative CRP is a predictive factor for prolonged hospital stay after radical cystectomy for bladder cancer," demonstrates that elevated C-reactive protein levels independently forecast extended hospitalization following radical cystectomy for bladder cancer. This finding has direct clinical relevance, offering surgeons a simple, low-cost tool for preoperative risk stratification and enhanced perioperative planning. By systematically analyzing patient characteristics, laboratory data, surgical factors, and postoperative complications, Horitani contributes to the growing evidence base for personalized surgical care and resource optimization in urologic oncology. His research bridges the gap between routine laboratory values and meaningful patient outcomes, helping to reduce hospital stays and improve recovery trajectories. With his work gaining traction in the urology community, Horitani is establishing himself as a thoughtful contributor to evidence-based surgical practice and postoperative risk assessment.
Research Focus
Key Achievements
Top Papers
- 1